Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Article in Periodical |
| Magazine / Source | Stem Cell Reviews and Reports |
| MU Faculty or unit | |
| Citation | |
| Web | https://link.springer.com/article/10.1007/s12015-021-10254-3 |
| Doi | http://dx.doi.org/10.1007/s12015-021-10254-3 |
| Keywords | iPSCs; Neural differentiation; Alzheimer’s disease; In vitro differentiation; Neural stem cells; Neural progenitors; Neurons; Astrocytes; Microglia; Cerebral organoids |
| Description | During the past two decades, induced pluripotent stem cells (iPSCs) have been widely used to study mechanisms of human neural development, disease modeling, and drug discovery in vitro. Especially in the field of Alzheimer’s disease (AD), where this treatment is lacking, tremendous effort has been put into the investigation of molecular mechanisms behind this disease using induced pluripotent stem cell-based models. Numerous of these studies have found either novel regulatory mechanisms that could be exploited to develop relevant drugs for AD treatment or have already tested small molecules on in vitro cultures, directly demonstrating their effect on amelioration of AD-associated pathology. This review thus summarizes currently used differentiation strategies of induced pluripotent stem cells towards neuronal and glial cell types and cerebral organoids and their utilization in modeling AD and potential drug discovery. |
| Related projects: |
|